Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-28 00:53:20 - browse：9123

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： VC firm RA Capital starts a new synthetic biology incubator

focus

WSS

As the dark side of IVF slowly comes into focus, even more transparency is needed

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

CDC: Cases of alpha

NIH trials fail to test meaningful long Covid therapies, experts say

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Public health communication lessons from Covid

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Medical records are filled with copy

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

State Dept. review finds Biden bears some blame for Afghanistan failures

Drastic changes should bring profitability, startup health insurers say

BioMarin wins approval for gene therapy to treat hemophilia A

Public health communication lessons from Covid

Moonlake's readout produced a cash windfall. Risks remain

American woman, child freed after being kidnapped in Haiti last month

explore

Man killed during FBI raid in connection with threats against Biden, other officials

Timeline: Special counsel's probe into Trump's handling of classified documents

An outrageous hospital charge: I paid $710 for an hour of babysitting

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

FDA panel issues narrow recommendation for Covid vaccine booster doses

hotspot

focus

focus

entertainment